| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.549 | 10.722 | 5.083 | 14.032 | 10.364 | 12.178 | 18.426 | 22.838 | 23.302 |
| Total Income - EUR | - | 7.557 | 10.722 | 5.091 | 14.032 | 10.373 | 12.208 | 18.426 | 29.868 | 23.855 |
| Total Expenses - EUR | - | 6.103 | 6.675 | 6.593 | 6.537 | 4.770 | 6.467 | 3.738 | 7.757 | 21.714 |
| Gross Profit/Loss - EUR | - | 1.454 | 4.047 | -1.502 | 7.494 | 5.604 | 5.741 | 14.687 | 22.111 | 2.140 |
| Net Profit/Loss - EUR | - | 1.227 | 3.725 | -1.655 | 7.073 | 5.293 | 5.383 | 14.244 | 18.512 | 1.245 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr.genes Med Orl Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 8.786 | 6.080 | 3.458 | 929 | 106 | 104 | 104 | 0 | 18.562 |
| Current Assets | - | 3.773 | 2.494 | 4.078 | 10.032 | 10.017 | 11.447 | 22.092 | 40.555 | 28.559 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 290 | 0 |
| Receivables | - | 1.050 | 1.199 | 646 | 622 | 611 | 1.249 | 835 | 923 | 501 |
| Cash | - | 2.723 | 1.296 | 3.432 | 9.410 | 9.406 | 10.198 | 21.257 | 39.342 | 28.058 |
| Shareholders Funds | - | 1.272 | 4.976 | 3.229 | 10.240 | 9.898 | 11.019 | 19.108 | 37.562 | 38.597 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 11.288 | 3.599 | 4.307 | 722 | 225 | 532 | 3.089 | 2.993 | 8.524 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr.genes Med Orl Srl